Development of a novel probe for measuring drug binding to the F1*S variant of human alpha 1-acid glycoprotein

Journal of Pharmaceutical Sciences

Volumn 90, Issue 9, 2001, Pages 1407-1423

  Cogswell, Lawrence P ^a,b   Raines, Douglas E ^c   Parekh, Sonali ^d   Jonas, Oliver ^a   Maggio, John E ^e   Strichartz, Gary R ^a,b,f  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD UNIVERSITY   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d BROWN UNIVERSITY   (United States)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Alpha 1 acid glycoprotein; Drug binding; Genetic variants; Methods; Probes

Indexed keywords

AMITRIPTYLINE; BUPIVACAINE; OROSOMUCOID;

ARTICLE; BINDING AFFINITY; DRUG BINDING SITE; DRUG PROTEIN BINDING; DRUG STABILITY; FLUORESCENCE; GENETIC VARIABILITY;

EID: 0034833662     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.1093     Document Type: Article

References (27)

1. Ligand specificity of the genetic variants of human alpha1-acid glyco-protein: Generation of a three-dimensional quantitative structure-activity relationship model for drug binding to the A variant
2. Drug binding to human alpha-1-acid glycoprotein in health and disease
3. The plasma protein binding of basic drugs
4. The genetic polymorphism of human alpha 1-acid glycoprotein
5. pH titration curves of the desialylated human alpha 1-acid glycoprotein variants by combined isoelectrofocusing-electrophoresis: Utilization in the development of a fractionation method for the protein variants by chromatography on immobilized metal affinity adsorbent
6. Evidence for differences in the binding of drugs to the two main genetic variants of human alpha 1-acid glycoprotein
7. Binding of disopyramide, methadone, dipyridamole, chlorpromazine, lignocaine and progesterone to the two main genetic variants of human alpha 1-acid glycoprotein: Evidence for drug-binding differences between the variants and for the presence of two separate drug-binding sites on alpha 1-acid glycoprotein
8. Structure and expression of the genes coding for human alpha 1-acid glycoprotein
9. Use of transgenic mice for the characterization of human alpha 1-acid glycoprotein (orosomucoid) variants
10. Fractionation of the genetic variants of human alpha 1-acid glycoprotein in the native form by chromatography on an immobilized copper(II) affinity adsorbent. Heterogeneity of the separate variants by isoelectrofocusing and by concanavalin A affinity chromatography
11. Separation of human orosomucoid major gene products using immobilized copper affinity chromatography and identification of the metal-interactive residues
12. Drug-protein binding sites. New trends in analytical and experimental methodology
13. Picosecond tryptophan fluorescence of human blood serum orosomucoid
14. ANS-drug interactions to AAG and HSA fluorescence and equilibrium dialysis studies
15. Pharmacology of local anaesthetic agents. Pharmacokinetics of local anaesthetic agents
16. Lipophilicity profiles of ampholytes
17. Ionization behavior and ionization-dependent conformation of raclopride, a dopamine D2 receptor antagonist
18. Fluorescence quenching of human orosomucoid. Accessibility to drugs and small quenching agents
19. 1-Anilino-naphthalene 8-sulfonic acid (ANS) as a probe for the binding of antidepressant drugs to human alpha 1-acid glycoprotein (AAG)
20. A general, wide-rage spectrofluorometric method for measuring the site- specific affinities of drugs toward human serum albumin
21. Comparative study of interaction mode of diazepines with human serum albumin and alpha 1-acid glycoprotein
22. Fluorescence studies of beta-adrenergic ligand binding to alpha 1-acid glycoprotein with 1-anilino-8-naphthalene sulfonate, isoprenaline, adrenaline and propranolol
23. Occurrence and possible function of inflammation-induced expression of sialyl Lewis-x on acute-phase proteins
24. Carbohydrate composition and immunomodulatory activity of different glycoforms of alpha1-acid glycoprotein
25. A novel two-site binding equation presented in terms of the total ligand concentration